Finance

Lists
Why is A58 up 2,84%?
Dive Deeper
A58:ETR
Elevance Health Inc
€369,60
+2,84%
(+10,20) 1D
9 Okt., 17:35:53 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for A58...
Open
€353,50
High
€369,60
Low
€352,50
Mkt. cap
86,95 mjd
Avg. vol.
11,00
Volume
0,00
52-wk high
€379,10
52-wk low
€241,60
No. of employees
97 k
Open
€353,50
High
€369,60
Low
€352,50
Mkt. cap
86,95 mjd
Avg. vol.
11,00
Volume
0,00
52-wk high
€379,10
52-wk low
€241,60
No. of employees
97 k
News stories
From web sources and news partners
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOGail Koziara Boudreaux
Employees96,6 k
Founded1944
HeadquartersIndianapolis, Indiana, Verenigde State van Amerika
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
50,71 mjd
49,75 mjd
50,18 mjd
50,47 mjd
Cost of goods sold
38,14 mjd
38,06 mjd
35,62 mjd
37,02 mjd
Cost of revenue
38,14 mjd
38,06 mjd
35,62 mjd
37,02 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,65 mjd
10,75 mjd
11,79 mjd
11,04 mjd
Operating expense
10,81 mjd
10,92 mjd
11,90 mjd
11,15 mjd
Total operating expenses
48,95 mjd
48,98 mjd
47,52 mjd
48,17 mjd
Operating income
1,76 mjd
766,00 m
2,66 mjd
2,30 mjd
Other non operating income
-
-
-
-
EBT including unusual items
1,41 mjd
215,00 m
2,30 mjd
1,94 mjd
EBT excluding unusual items
1,41 mjd
399,00 m
2,30 mjd
1,94 mjd
Income tax expense
219,00 m
-331,00 m
544,00 m
483,00 m
Effective tax rate
15,58%
-153,95%
23,61%
24,94%
Other operating expenses
-
-
-
-
Net income
1,19 mjd
547,00 m
1,76 mjd
1,46 mjd
Net profit margin
2,34%
1,10%
3,52%
2,90%
Earnings per share
6,03
3,33
12,58
7,45
Interest and investment income
-
-
-
-
Interest expense
-351,00 m
-367,00 m
-357,00 m
-364,00 m
Net interest expenses
-351,00 m
-367,00 m
-357,00 m
-364,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
2,14 mjd
1,17 mjd
3,02 mjd
2,67 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme